Evaluation of potential hepatic recompensation criteria in patients with <scp>PBC</scp> and decompensated cirrhosis
Benedikt Hofer(Austrian Academy of Sciences), Thomas Reiberger(ERN GUARD-Heart), Emina Halilbasic(Medical University of Vienna), Oleksandr Petrenko(Austrian Academy of Sciences), Albert Friedrich Stättermayer(Medical University of Vienna), Michael Trauner(Medical University of Vienna), Mattias Mandorfer(Medical University of Vienna), Lukas Burghart(Medical University of Vienna), Benedikt Simbrunner(Austrian Academy of Sciences)
Cited by 31
Related Papers
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
|Gastroenterology|2014|563
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
|Annual Review of Pathology Mechanisms of Disease|2018|561
Pathophysiological mechanisms of liver injury in COVID‐19
|Liver International|2020|399